Skip to Main Content

Author Details

David S Rickman
Meyer Cancer Center
2001
59
37
PMIDPaper TitleJournal TitlePublished Year
37034687Distinct mesenchymal cell states mediate prostate cancer progression.bioRxiv2023
37546702The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.Cancer Res Commun2023
34676924Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.Adv Mater2022
35848798AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.Elife2022
36511483Defining cellular population dynamics at single-cell resolution during prostate cancer progression.Elife2022
34312180RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.Cancer Res2021
34099734Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.Nat Commun2021
30901730Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.Neoplasia2019
30232224A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.Clin Cancer Res2019
31260412N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.J Clin Invest2019
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
30894499Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.Sci Transl Med2019
29358508The Expanding World of N-MYC-Driven Tumors.Cancer Discov2018
28864460A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.Cold Spring Harb Mol Case Stud2017
29262328Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle.Cell Rep2017
28750683Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.Genome Biol2017
28586335Biology and evolution of poorly differentiated neuroendocrine tumors.Nat Med2017
27264179A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.Cell Rep2016
27728805N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.Cancer Cell2016
26181256Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.JAMA Oncol2015
24727321Aggressive variants of castration-resistant prostate cancer.Clin Cancer Res2014
25420520ERG induces taxane resistance in castration-resistant prostate cancer.Nat Commun2014
21600800Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.Urol Oncol2013
23716562CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.Haematologica2013
22615383Oncogene-mediated alterations in chromatin conformation.Proc Natl Acad Sci U S A2012
22918253Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.Cell Cycle2012
22496589Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.Proc Natl Acad Sci U S A2012
22555088Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.Diagn Mol Pathol2012
21036922Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.Genome Res2011
22389870Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.Cancer Discov2011
21791045Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies.J Transl Med2011
19795456Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.Int J Cancer2010
21170267ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.Neoplasia2010
20822523An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients.Mol Cancer2010
20018353ERG rearrangement metastasis patterns in locally advanced prostate cancer.Urology2010
19293179SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.Cancer Res2009
19649210N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.Neoplasia2009
19762526In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.Am J Clin Pathol2009
19530245WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?Genes Chromosomes Cancer2009
19139432Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.J Clin Oncol2009
19156837Distinct genomic aberrations associated with ERG rearranged prostate cancer.Genes Chromosomes Cancer2009
18038450Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.Hepatology2008
19061838Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.Cancer Cell2008
18615101The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.Leukemia2008
18679425Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.Oncogene2008
18320074EML4-ALK fusion lung cancer: a rare acquired event.Neoplasia2008
17187432Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.Hepatology2007
17388661Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.PLoS Med2007
17284527The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.Blood2007
17077326Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.Blood2007
  • 1 - 50 of 59

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 14
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 5
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 14
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 13
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 30
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 7
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 4
John R Prensner
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 15
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 9
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 1
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 3
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 25
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 3
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 15
Anna Lapuk
Contextual Genomics Inc.
Career Start Year 1998
Number of shared co-authors 9
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 1
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 6
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 8
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 32
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 3
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 3
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 3
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 25
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 6
Jeremy Clark
Norwich Medical School, University of East Anglia
Career Start Year 1989
Number of shared co-authors 1
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 26
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 7

Collaborators

Mark A Rubin
University of Bern
Co-authored papers 29
Francesca Demichelis
University of Trento
Co-authored papers 16
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 15
Olivier Elemento
Meyer Cancer Center
Co-authored papers 12
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers 12
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers 8
Loredana Puca
Sandra and Edward Meyer Cancer Center
Co-authored papers 7
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 7
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers 7
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 7
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 7
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 6
Naoki Kitabayashi
Co-authored papers 6
Ashutosh K Tewari
Co-authored papers 5
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Co-authored papers 5
Rohan Bareja
Case Western Reserve University
Co-authored papers 5
Yuzhuo Wang
University of British Columbia
Co-authored papers 4
Cynthia Cheung
Chaminade University of Honolulu
Co-authored papers 4
Dorothee Pflueger
Co-authored papers 4
Christopher E Barbieri
Weill Cornell Medical College
Co-authored papers 4
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Martin E Gleave
University of British Columbia
Co-authored papers 4
Kyung Park
New York University Langone Health
Co-authored papers 4
Mark Gerstein
Yale University
Co-authored papers 4
Robert Kim
University of California
Co-authored papers 4
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 3
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 3
Douglas S Scherr
New York-Presbyterian Hospital
Co-authored papers 3
David Wilkes
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 3
Raquel Esgueva
Co-authored papers 3
Release 1.2